Outcomes Associated with Introduction of the 5th Generation High-Sensitivity Cardiac Troponin in Patients Presenting with Cardiovascular Disorders
Arwa Younis(Cleveland Clinic), Ilan Goldenberg(Sheba Medical Center), John P. Gassler(Cleveland Clinic), Shamroz Farooq(University of Rochester Medicine), Thomas R. Welch(St Joseph's Hospital Health Center), Alexander Diamond(University of Rochester Medicine), John D. Bisognano(University of Michigan), Andrew Mathias(University of Rochester Medicine), Anita Y. Chen(University of Rochester Medicine), Scott McNitt(University of Rochester), Mehmet K. Aktaş(University of Rochester Medical Center)
Cited by 4
Related Papers
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
|Circulation|2009|1k
Clinical Practice Guidelines for the Management of Hypertension in the Community
|Journal of Clinical Hypertension|2013|1k
Clinical Practice Guidelines for the Management of Hypertension in the Community
|Journal of Hypertension|2013|685
Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes
|Journal of the American College of Cardiology|2005|658